Follow
Raritan Pharmaceuticals has issued a recall of its belladonna-based products.
Raritan Pharmaceuticals has issued a recall of its belladonna-based products as the substance may determine potentially life-threatening adverse effects.
The voluntary recall was announced through a MedWatch alert hosted by the United States Food and Drug Administration or FDA.
Raritan Pharmaceutics is a United- States-based company which offers generic and innovative pharmaceuticals, medical devices, consumer products, and high-end cosmetics.
Raritan is the contract manufacturer of the belladonna-based products meant for Homeolab USA. Homeolab USA is also the provider of the belladonna blends used as part of the Raritan products.
The aforementioned company decided to voluntarily recall its homeopathic products which contain the blends after it noticed the potential variation in its content.
Raritan determined that belladonna extract content could vary, which could potentially lead to undeterminable side effects.
According to their announcement, the FDA declared to have tested the respective products. Its testing determined that the products could have a different belladonna quantity than the one printed on the label.
Belladonna, which is also known as deadly nightshade, is known for both its beneficial and its potentially life-threatening effects.
Most belladonna products are used in homeopathic treatments and cures. Homeopathic practices maintain that a small dosage of the cause of suffering may determine a faster cure.
It also believes that the same small dosages may prevent a future health problem.
However, belladonna may have unpredictable effects as it could be used as a poison or have deadly effects when taken in higher dosages.
Despite its threatening and often unpredictable results, man has been using the plant in both medicine and cosmetic products.
The recall was issued as based on the unpredictable effects in may have on the consumer’s health. As the dosage contained is different than the one shown on the label, it may be either higher or lower.
A lower dosage would have no effects whatsoever whilst a higher dosage may lead to an involuntary poisoning.
The products to have been recalled have had a nationwide distribution and may also include medicine targeting children.
Raritan included, in the belladonna recall, the CVS Homeopathic Infants’ Teething tablets which have already been recalled by CVS.
The latest FDA alert also includes the Kids Relief Homeopathic Ear Relief Oral Liquid and the CVS Homeopathic Kids’ Ear Relief Liquid.
These products are meant to have a very small dosage of belladonna, but as the quantity may value, they have also been recalled.
No health problem cases have been reported in relation to any of these homeopathic products. Raritan stated that the company has issued the voluntary call in an abundance of caution as it does not wish for any health problems.
Besides the designated list of belladonna-based products, no other Homeolab or Raritan products have been affected.
The full, detailed specifications and the list of recalled products can be consulted on the FDA website.
Consumers that own such products are strongly advised to stop using them, and also contact their health care providers if they have questions.
They should also be immediately contacted if the consumers believe that they may be experiencing health issues in relation to the products.
Image Source: Wikimedia
